Christina Charles-Schoeman, MD, MS

Dr. Charles-Schoeman is a Professor of Medicine and Chief of the Division of Rheumatology at the University of California in Los Angeles (UCLA). Over a decade ago she developed the UCLA myositis program and specializes in the care of patients with autoimmune inflammatory myopathies, often treating patients with aggressive systemic disease including interstitial lung disease. Her research interests include the study of vascular disease and inflammatory lipoproteins as targets for systemic disease treatment in patients with autoimmune disease including myositis, and she is also an active investigator in several clinical trials of novel therapies for these diseases.
Financial relationships
-
Attribution:SelfType of financial relationship:ConsultantIneligible company:AbbvieTopic:Rheumatoid ArthritisDate added:07/15/2026Date updated:07/15/2026
-
Attribution:SelfType of financial relationship:ConsultantIneligible company:Sana BiotechnologyTopic:Rheumatoid arthritisDate added:07/15/2026Date updated:07/15/2026
-
Attribution:SelfType of financial relationship:ConsultantIneligible company:OctapharmaTopic:MyositisDate added:07/15/2026Date updated:07/15/2026
-
Attribution:SelfType of financial relationship:ConsultantIneligible company:ImmunovantTopic:Rheumatoid arthritisDate added:07/15/2026Date updated:07/15/2026
-
Attribution:SelfType of financial relationship:ConsultantIneligible company:PfizerTopic:Myositis and JAK inhibitorsDate added:07/15/2026Date updated:07/15/2026
-
Attribution:SelfType of financial relationship:ConsultantIneligible company:Bristol Myers SquibbTopic:Psoriatic arthritisDate added:07/15/2026Date updated:07/15/2026
-
Attribution:SelfType of financial relationship:ConsultantIneligible company:Boehringer IngelheimTopic:Myositis and Lung DiseaseDate added:07/15/2026Date updated:07/15/2026
-
Attribution:SelfType of financial relationship:ConsultantIneligible company:PriovantTopic:MyositisDate added:07/15/2026Date updated:07/15/2026
-
Attribution:SelfType of financial relationship:ConsultantIneligible company:ArgenxTopic:MyositisDate added:07/15/2026Date updated:07/15/2026

Facebook
X
LinkedIn
Forward